Replies to post #108782 on Avid Bioservices Inc (CDMO)

[BioBS2012]

Thanks FTM. Will be interesting to see what the Phase III OS data looks like tomorrow. Appreciate the research.

GLTA

[sunstar]

Peregrine ran ECOG 0,1 and 2 patients in their pancreatic trial. 72% of patients in the Gem + Bavi arm were ECOG 1 and 2.

http://www.peregrineinc.com/images/stories/pdfs/pancreatic_2012_aacr_poster.pdf

Thanks for following this.

IMO

sunstar

[exwannabe]

Re: Abraxane and Bavi in pancreatic

If one believes in Bavi, then one would expect it to be synergetic with a taxane. So Abraxane's effectiveness does not really change the game.

As to point values, what counts is how well Bavi+Gem does vs Gem, not how these numbers compare to other trials.

It is true that an Abraxane win could delay bavi in this space as it might well need to trial the triple combination.